Williams Syndrome Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study
Williams Syndrome SHAAPE STUDY [Strength, Hormones, Activity & Adiposity, DNA Programming, Eating Study]
Sponsor: Massachusetts General Hospital
Listed as NCT03758651, this observational or N/A phase trial focuses on Lipedema and Williams Syndrome and remains completed. Sponsored by Massachusetts General Hospital, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2022 — Nov 2023 [monthly]
Active Not Recruiting
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting
-
May 2020 — Jan 2021 [monthly]
Recruiting
-
Dec 2018 — May 2020 [monthly]
Recruiting
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
- Williams Syndrome Association
For direct contact, visit the study record on ClinicalTrials.gov .